Literature DB >> 6310723

Immunocytological studies of Epstein-Barr viral antigen and antibody in rheumatoid synovial fluids.

J P de Champlain, T D Kinsella, M J Fritzler, B Werschler.   

Abstract

Evidence for intra-articular immunity to Epstein-Barr virus (EBV) was sought in synovial fluids (SF) and SF phagocytes derived from patients with and without rheumatoid arthritis (RA). Antibody titres to EBV were not significantly different in SF of 32 RA and 25 non-RA patients. Whereas the majority of RA patients (69%) showed Ig-containing complexes (IC) in SF phagocytes, fluorescent antibody staining of these by anti-EBV serum was negative except with 6 RA patients. Extended analysis of the SF phagocytes of the latter, however, showed no EBV specificity in their IC, suggesting that these represented non-specific "pseudo-IC'. These studies do not support a role for EBV-containing IC in the propagation of rheumatoid synovitis and demonstrate that not all immunofluorescent inclusions in RA phagocytes (ragocytes) represent immune complexes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310723     DOI: 10.1007/bf00541228

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  22 in total

1.  STUDIES ON THE PATHOGENESIS OF RHEUMATOID JOINT INFLAMMATION. I. THE "R.A. CELL" AND A WORKING HYPOTHESIS.

Authors:  J L HOLLANDER; D J MCCARTY; G ASTORGA; E CASTRO-MURILLO
Journal:  Ann Intern Med       Date:  1965-02       Impact factor: 25.391

Review 2.  Recent insights into the pathogenesis of the proliferative lesion in rheumatoid arthritis.

Authors:  E D Harris
Journal:  Arthritis Rheum       Date:  1976 Jan-Feb

3.  Dunlop-Dottridge lecture. Rehumatoid arthritis, rheumatoid factor and the Epstein-Barr virus.

Authors:  J H Vaughan
Journal:  J Rheumatol       Date:  1979 Jul-Aug       Impact factor: 4.666

4.  Presence of aggregated gamma-G-globulin in certain rheumatoid synovial effusions.

Authors:  K Hannestad
Journal:  Clin Exp Immunol       Date:  1967-07       Impact factor: 4.330

5.  The effects of chemical modifications of human gamma-globulins on their interaction with rheumatoid factors and antibodies.

Authors:  S Bozsoky; E C Franklin
Journal:  Arthritis Rheum       Date:  1966-06

6.  Intracytoplasmic inclusions of immunoglobulins in rheumatoid arthritis and other diseases.

Authors:  J H Vaughan; E V Barrnett; M V Sobel; R F Jacox
Journal:  Arthritis Rheum       Date:  1968-04

7.  T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.

Authors:  G Tosato; I T Magrath; R M Blaese
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

8.  Studies of circulating immune complexes in ankylosing spondylitis.

Authors:  T D Kinsella; C Lanteigne; R M Lewkonia; M J Fritzler
Journal:  Clin Invest Med       Date:  1982       Impact factor: 0.825

9.  The infectious etiology of rheumatoid arthritis. New considerations.

Authors:  J C Bennett
Journal:  Arthritis Rheum       Date:  1978-06

10.  Cathepsin D agglutinators in rheumatoid arthritis. I. Increased CDA titers in serum and synovial fluid of patients with seropositive RA.

Authors:  G Artmann; K Fehr; A Boni
Journal:  Arthritis Rheum       Date:  1977-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.